HETROLAXA 10MG/3.5G/12G POWDER FOR ORAL SOLUTION

Indications

• Acidulant in food and beverages
• Preservative in pharmaceutical formulations
• pH adjuster in various chemical preparations

Dosage

Children: Refer to product-specific guidelines for appropriate dosing based on formulation and indication.

Adults: Refer to product-specific guidelines for appropriate dosing based on formulation and indication.

Mechanism of action

Citric acid acts by chelating metal ions, which can enhance the solubility of certain compounds and improve their bioavailability. It also contributes to the acidity of the environment, which can influence enzymatic activity and metabolic pathways, particularly in the degradation of citronellol.

Pharmacodynamics

Citric acid exhibits mild pharmacological effects primarily attributed to its role in metabolic processes. It aids in the regulation of pH levels, which can impact enzymatic reactions and biochemical pathways. The acid's chelating properties may help to reduce the toxicity of certain metal ions in biological systems.

Pharmacokinetics

Citric acid is rapidly absorbed after oral administration and is metabolized in the liver. It undergoes conversion to various metabolites in the citric acid cycle, contributing to energy production. The elimination primarily occurs through urine, with minimal accumulation in the body.

Pregnancy

Citric acid is generally regarded as safe during pregnancy when used in food amounts. However, consult a healthcare provider for advice on medicinal use.

Breast-feeding

Citric acid is considered safe during breastfeeding when consumed in food amounts. For medicinal use, consult a healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight.

Mechanism of action

Oxides do not have a single mechanism of action as they are a broad category of compounds. However, in general, metal oxides can exhibit catalytic properties, while non-metal oxides may participate in biochemical reactions by forming acids or bases upon dissolution in water.

Pharmacodynamics

The pharmacodynamics of oxides depend on the specific type of oxide and its interaction with biological systems. For instance, metal oxides may have antimicrobial properties, while certain non-metal oxides can influence metabolic pathways through their acid-base chemistry. The effects vary widely, necessitating specific studies for each oxide's role in therapeutic contexts.

Pharmacokinetics

The pharmacokinetics of oxides are also variable. Many metal oxides are poorly soluble and thus have limited absorption when ingested. Non-metal oxides, such as carbon dioxide, can be readily absorbed and utilized in metabolic processes. The distribution, metabolism, and excretion of oxides depend on their chemical form and the biological system in which they are involved.

Pregnancy

Not applicable as oxide is not a drug but a class of chemical compounds.

Breast-feeding

Not applicable as oxide is not a drug but a class of chemical compounds.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Bowel preparation prior to colonoscopy
• Preparation for other gastrointestinal diagnostic procedures

Dosage

Children: For children, the dosage must be determined according to age and weight. Refer to the BNF for Children for specific dosing guidelines.

Adults: For adults, the typical dosage for bowel preparation is 20 mg of sodium picosulfate (or as directed on the product label), usually taken in the evening before the procedure, often combined with magnesium citrate.

Mechanism of action

Sodium picosulfate is a contact laxative that inhibits the absorption of water and electrolytes while increasing their secretion into the intestinal lumen. It is converted by colonic bacterial enzyme sulfatase into an active metabolite, bis-(p-hydroxy-phenyl)-pyridyl-2-methane (BHPM), which acts directly on the colonic mucosa to stimulate colonic peristalsis.

Pharmacodynamics

Sodium picosulfate is classified as a stimulant laxative and has been shown to effectively produce a purgative effect in conjunction with magnesium citrate. In clinical studies, a significant majority of patients undergoing colonoscopy reported that sodium picosulfate-containing preparations provided effective bowel cleansing.

Pharmacokinetics

Sodium picosulfate is converted in the colon by bacterial enzymes into its active form, which exerts its effects locally in the colonic mucosa. The onset of action typically occurs within 6 to 12 hours after administration, depending on individual factors such as gastrointestinal motility.

Contra-indications

• Hypersensitivity to picosulfate or any of its components
• Severe dehydration
• Intestinal obstruction
• Appendicitis
• Acute abdominal pain of unknown origin
• Severe inflammatory bowel disease

Adverse effects

• Abdominal cramps
• Diarrhea
• Nausea
• Vomiting
• Electrolyte imbalance
• Dehydration

Interactions

• May interact with other laxatives, increasing the risk of dehydration and electrolyte imbalance
• Potentially alters the absorption of other medications taken simultaneously

Precautions

• Use with caution in patients with renal impairment
• Monitor electrolytes in prolonged use
• Not recommended for use in children under 12 years unless advised by a healthcare professional

Pregnancy

There is limited data on the use of sodium picosulfate during pregnancy. It should only be used if clearly needed and prescribed by a healthcare provider.

Breast-feeding

Sodium picosulfate is excreted in breast milk, but at therapeutic doses, it is not expected to adversely affect the nursing infant. Caution is advised.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Oral solution
• Tablets

Mechanism of action

Picosulfuric acid, as sodium picosulfate, is a contact laxative. Sodium picosulfate inhibits the absorption of water and electrolytes, and increases their secretion into the intestinal lumen. It is hydrolyzed by colonic bacterial enzyme, sulfatase, to form an active metabolite bis-(p-hydroxy-phenyl)-pyridyl-2-methane (BHPM), which acts directly on the colonic mucosa to stimulate colonic peristalsis.

Pharmacodynamics

Sodium picosulfate is a stimulant laxative that in conjunction with magnesium citrate, produces a purgative effect on stools. In a multicentre, observational study comprising of patients undergoing colonoscopy, more than 93.0% of the patients receiving sodium picosulfate-containing preparations reported the colon cleansing effect to be effective.